MusclePharm Corporation Share Price

Stocks

18/23/18	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
10/23/10	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI
03/23/03	Motion for Asset Sale Approved for MusclePharm Corporation	CI
27/23/27	FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	CI
08/23/08	Stalking Horse Agreement Filed by MusclePharm Corporation	CI
01/23/01	Musclepharm Corporation Announces Resignation of Paul Karr as Director	CI
28/23/28	Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
28/23/28	First Amended Disclosure Statement Approved for MusclePharm Corporation	CI
17/23/17	Bidding Procedure Approved for MusclePharm Corporation	CI
20/23/20	Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	CI
19/23/19	First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	CI
26/23/26	Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
12/23/12	Motion for Asset Sale Filed by MusclePharm Corporation	CI

28/23/28	SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	AQ
30/22/30	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
19/22/19	MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	PU
19/22/19	MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	AQ
24/22/24	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ

Manager	Title	Age	Since
Tyler Jeffrey Dillashaw PRN	Corporate Officer/Principal	-	01/10/2021
Jason Keenan PRN	Corporate Officer/Principal	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
29/03/22	White Winston Select Asset Funds LLC	Sell	Company	6,26,826	1.8775%
21/12/21	Sabina Rizvi	Free	Chairperson	18,11,000	5.4244%
01/04/21	Sabina Rizvi	Other	President & CFO	0	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MUSCLEPHARM CORPORATION	-.--%	-.--%	-	-	33
BOXABL INC.	-1.93%	+9.05%	-53.83%	-	1.34TCr
FREENOME, INC.	+11.61%	+3.53%	+5.49%	-	123.13Cr
CHURCHILL CAPITAL CORP XI	-0.45%	+6.06%	-	-	86Cr
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	0.00%	-	-	64Cr
CENTIEL AG	+5.92%	+13.49%	+315.66%	-64.43%	65Cr
CHURCHILL CAPITAL CORP XII	-0.65%	0.00%	-	-	60Cr
DEEP FISSION, INC.	-8.27%	-7.99%	-	-	55Cr
BAIN CAPITAL GSS INVESTMENT CORP.	0.00%	-0.39%	-	-	60Cr
Average	+0.81%	+1.22%	+89.11%	-64.43%	231.37Cr
Weighted average by Cap.	-0.67%	+11.56%	-33.37%	-64.43%